|Born||June 6, 1950|
|Alma mater||Colgate University (1972, B.A.)|
Yale School of Medicine (1977, M.D.)
|Occupation||Founder and Former Chairman & CEO of ARIAD Pharmaceuticals|
|Board member of||Dana-Farber Cancer Institute|
Harvey J. Berger, M.D. is an American physician-scientist, entrepreneur and biotechnology executive. He was the founder and chairman and chief executive officer of ARIAD Pharmaceuticals, Inc. for 25 years, starting in 1991 and became advisor to the board in 2016. He was also executive chairman at Medinol, Inc from 2017 to 2018. In February 2018, Berger was appointed to the Dana-Farber Cancer Institute Board of Trustees.